These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22239125)

  • 1. The effects of immunosuppressants on vascular function, systemic oxidative stress and inflammation in rats.
    Shing CM; Fassett RG; Brown L; Coombes JS
    Transpl Int; 2012 Mar; 25(3):337-46. PubMed ID: 22239125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial.
    Gullestad L; Iversen M; Mortensen SA; Eiskjaer H; Riise GC; Mared L; Bjørtuft O; Ekmehag B; Jansson K; Simonsen S; Gude E; Rundqvist B; Fagertun HE; Solbu D; Bergh CH
    Transplantation; 2010 Apr; 89(7):864-72. PubMed ID: 20061999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
    Patsenker E; Schneider V; Ledermann M; Saegesser H; Dorn C; Hellerbrand C; Stickel F
    J Hepatol; 2011 Aug; 55(2):388-98. PubMed ID: 21168455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
    DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
    Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of cyclosporine and tacrolimus vs newer immunosuppressants mycophenolate mofetil and rapamycin on coronary endothelial function.
    Jeanmart H; Malo O; Carrier M; Nickner C; Desjardins N; Perrault LP
    J Heart Lung Transplant; 2002 Sep; 21(9):990-8. PubMed ID: 12231370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of cyclosporine A on the reactivity of the aorta with regenerated endothelium in rats].
    Dagenais F; Hollmann C; Buluran J; Cartier R
    Ann Chir; 1995; 49(8):694-9. PubMed ID: 8561423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.
    Ramzy D; Rao V; Tumiati LC; Xu N; Miriuka S; Delgado D; Ross HJ
    Circulation; 2006 Jul; 114(1 Suppl):I214-9. PubMed ID: 16820575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus with reduced-dose cyclosporine versus full-dose cyclosporine and mycophenolate in de novo renal transplant patients: a 2-year single-center experience.
    Santos SM; Carlos CM; Cabanayan-Casasola CB; Danguilan RA
    Transplant Proc; 2012 Jan; 44(1):154-60. PubMed ID: 22310603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
    Koster RA; Dijkers EC; Uges DR
    Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus preserves vasomotor function and maintains vascular homeostasis.
    Tepperman ED; Tumiati LC; Ramzy D; Badiwala MV; Sheshgiri R; Prodger JL; Ross HJ; Rao V
    J Heart Lung Transplant; 2011 May; 30(5):583-8. PubMed ID: 21273094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose calcineurin inhibitor regimen combined with mammalian target of rapamycin inhibitors preserves kidney functions in renal transplant recipients without allograft nephropathy.
    Kacar S; Gurkan A; Karaca C; Varılsuha C; Tilif S
    Transplant Proc; 2010 Nov; 42(9):3513-6. PubMed ID: 21094806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in glucose metabolism by cyclosporine in rat brain slices link to oxidative stress: interactions with mTOR inhibitors.
    Christians U; Gottschalk S; Miljus J; Hainz C; Benet LZ; Leibfritz D; Serkova N
    Br J Pharmacol; 2004 Oct; 143(3):388-96. PubMed ID: 15339861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
    Jensen GS; Wiseman A; Trotter JF
    Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
    [No Abstract]   [Full Text] [Related]  

  • 16. What does the CONVERT trial really tell us about conversion from calcineurin inhibitors to sirolimus?
    Hanto DW; Chudzinski R
    Transplantation; 2009 Jan; 87(2):164-5. PubMed ID: 19155968
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of everolimus on cytokines, oxidative stress, and renal histology in ischemia-reperfusion injury of the kidney.
    Suyani E; Derici UB; Sahin T; Ofluoglu E; Pasaoglu H; Erdem O; Barit G; Reis KA; Erten Y; Arinsoy T; Sindel S
    Ren Fail; 2009; 31(8):698-703. PubMed ID: 19814637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension induced by immunosuppressive drugs: a comparative analysis between sirolimus and cyclosporine.
    Reis F; Parada B; Teixeira de Lemos E; Garrido P; Dias A; Piloto N; Baptista S; Sereno J; Eufrásio P; Costa E; Rocha-Pereira P; Santos-Silva A; Figueiredo A; Mota A; Teixeira F
    Transplant Proc; 2009 Apr; 41(3):868-73. PubMed ID: 19376375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.